09606.HK
Duality Biotherapeutics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 180.70
−1.53%Margins
Gross margin
-27.7%
EBITDA margin
-182.3%
EBIT margin
-185.3%
Net margin
-170.8%
FCF margin
-48.0%
-99.2%
Return on equity
-41.0%
Return on assets
-85.3%
Return on invested capital
0.24x
Asset turnover
-HKD 460.6M
Cash from operations
HKD 54
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026